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Bypass for chronic ischemia of the upper
extremity: Results in 20 patients
Kakra Hughes, MD, Allen Hamdan, MD, Marc Schermerhorn, MD, Anthony Giordano, BS,
Sherry Scovell, MD, and Frank Pomposelli, Jr, MD, Boston, Mass
Objective: Chronic ischemia of the upper extremity requiring surgical revascularization is an uncommon condition. We
analyzed modes of presentation, methods of operative repair, and follow-up in all consecutive patients with chronic
ischemia of the upper extremity requiring arterial bypass.
Methods:Data prospectively entered into a vascular registry was retrospectively analyzed for all patients undergoing upper
extremity arterial bypass from January 1, 1990, to June 30, 2003. Simple thromboembolectomy procedures and bypasses
to an outflow target more proximal than the brachial artery were excluded.
Results:We identified 20 patients. Their mean age was 57 years, and 11 (55%) were women. Eight (40%) had diabetes, and
five (25%) had renal insufficiency. Indications included exercise intolerance in 11 patients (55%), tissue loss in six (30%),
and rest pain in three (15%). The etiology of ischemia was atherosclerosis in seven patients (35%) and complications of
iatrogenic or civilian trauma in 13 (65%). The brachial artery was used as the inflow in 13 patients (65%), the axillary in
six (30%), and the ulnar in one (5%). Conduits used included the great saphenous vein in 11 patients (55%), arm vein in
7 (35%), and prosthetic in 2 (10%). Outflow targets included the brachial artery in 12 patients (55%), the radial in five
(25%), and the ulnar in three (15%). There were no perioperative deaths. One graft (5%) occluded <30 days of surgery.
Mean follow-up was 12 months. Mean survival after bypass was 62 months. Patency at 1 and 3 years was 85%. Two
patients had associated minor amputations (a finger and a partial hand). Limb salvage rate was 100%.
Conclusion: Although upper extremity ischemia is rare, results for upper extremity bypass are excellent and superior to
those reported for lower extremity ischemia. These results may reflect the indications, which differ considerably from
those for lower extremity bypass, with the most being performed for complications of trauma. (J Vasc Surg 2007;46:
303-7.)Arterial reconstruction for the treatment of chronic
upper extremity ischemia is infrequently performed in a
vascular surgical practice. Furthermore, many of the rela-
tively few reports documenting the results of such opera-
tions have included bypass for both acute and chronic
ischemia as well as bypass to the subclavian and axillary
arteries.1-4 This study was undertaken to report our expe-
rience with arterial reconstruction of the upper extremity
for the treatment of chronic ischemia, focusing exclusively
on bypass to the brachial and infrabrachial arteries.
METHODS
The vascular registry of a single university hospital was
searched to identify those patients who had a brachial or
infrabrachial artery as an outflow target in all consecutive
upper extremity arterial reconstructions performed be-
tween January 1990 and June 2003. Thromboembolec-
tomy procedures (with or without patch angioplasty) and
bypasses with an outflow target more proximal than the
brachial artery were excluded. Also excluded were patients
undergoing bypass for ischemia related to acute trauma and
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procedure.
Patients presenting with exercise intolerance, rest pain,
or tissue loss underwent an initial clinical assessment, fol-
lowed by preoperative arterial imaging. Preoperative du-
plex ultrasound vein mapping was used liberally to locate a
suitable venous conduit. Any necessary débridement of
gangrenous tissue was done preoperatively (for wet gan-
grene) or at the time of operation. No perioperative ampu-
tations were done in this group.
Postoperatively, patients were followed up at regular
intervals of about every 3months during the first year, every
6 months during the second year, and annually thereafter.
Graft patency was determined by the presence of a palpable
pulse in the graft by the attending surgeon. In the latter
years of the study, duplex graft surveillance was often used,
although this was not done universally. Death during
follow-up was determined from the Social Security Death
Index. In a limited fashion, patient demographics and
indications for bypass in this group were then compared
with a cohort of lower extremity bypass patients at our
institution5 (bypasses performed from July 1990 to July
1993).
All data were prospectively entered at the time of
treatment into a vascular registry and the registry updated
periodically with patient follow-up information. Data in-
cluded demographics, indications for surgery, comorbid
conditions, specific operative details, complications, and
outcomes. A retrospective query of the database and chart
reviews were done for this study. All data are presented in
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Council of The Society for Vascular Surgery and The
American Association of Vascular Surgery.6
Graft patency, limb salvage, and patient survival were
calculated using the Kaplan-Meier life-table method. Com-
parisons were made using the nonparametric Mantel-Cox
log-rank test. Categoric variables and continuous variables
were compared with the 2 and Student t test, respectively.
A value of P  .05 was considered statistically significant.
RESULTS
From January 1990 to June 2003, 20 bypasses were
performed to the brachial or infrabrachial artery in 20
patients.Mean age was 57 years (range, 34 to 80 years), and
11 patients (55%) were women. Nine patients (45%) had
hypertension, 8 (40%) had diabetes mellitus, 10 (50%) had
coronary artery disease, and 5 (25%) had dialysis-dependent
renal failure (4 on hemodialysis and 1 on peritoneal dialy-
sis). Indications for bypass included exercise intolerance in
11 patients (55%), rest pain in three (15%), and tissue loss
in six (30%). The etiology of ischemia was atherosclerosis in
seven patients (35%) and previously untreated iatrogenic or
civilian trauma in 13 (65%). The brachial artery was used as
the inflow source in 13 patients (65%), the axillary in six
(30%) and the ulnar artery in one (5%). Conduits used
consisted of the great saphenous vein in 11 patients (55%),
an arm vein in seven (35%), and polytetrafluoroethylene
(PTFE) in two (10%). Outflow targets were the brachial
artery in 12 patients (60%), the radial artery in five (25%)
and the ulnar artery in three (15%; Table I).
When patients who had undergone bypass for previ-
ously untreated trauma were compared with those under-
going bypass for atherosclerosis (Table II), some interest-
ing observations were noted, although the very small
numbers would not allow for meaningful statistical com-
parison. The six patients undergoing bypass for tissue loss
had atherosclerosis as their etiology, whereas none of the
patients with previously untreated trauma had tissue loss.
Conversely, all of the patients undergoing bypass for exer-
tional symptoms were patients with previously untreated
trauma. Also, four of the five patients with dialysis-dependent
Table I. Conduits and inflow and outflow arteries
N (%)
Conduit
Great saphenous 11 (55)
Arm vein 7 (35)
Prosthetic 2 (10)
Inflow artery
Brachial 13 (65)
Axillary 6 (30)
Ulnar 1 (5)
Outflow artery
Brachial 12 (60)
Radial 5 (25)
Ulnar 3 (15)renal failure were patients undergoing bypass for atheroscle-rosis. Anotherworthwhile observationwas that five (71%) of
seven patients with atherosclerosis had undergone a previ-
ous lower extremity bypass compared with three (23%) of
13 patients who had previously untreated trauma. Patients
undergoing bypass for atherosclerosis also tended to have
more distal outflow targets, with five (71%) of seven having
an infrabrachial outflow artery compared with three (23%)
of 13 for the previously untreated trauma subgroup of
patients.
There were no perioperative deaths, no perioperative
cardiac complications, and no incidence of postoperative
pulmonary or renal failure in this series of upper extremity
bypass patients. Average length of stay was 3 days (range, 1
to 7 days). One bypass graft (5%) occluded on postopera-
tive day 12 without attempted revision. Revision was not
attempted because an intraoperative decision had been
made that in consideration of the borderline nature of the
distal target, reoperation would not be undertaken if the
graft failed. This was in a 40-year-old woman (Table III,
patient 1), with diabetes mellitus, hypertension, coronary
artery disease, and chronic renal failure on hemodialysis
who underwent a brachial-to-radial artery bypass using
cephalic vein for gangrenous fingers caused by atheroscle-
rotic occlusive disease. She subsequently underwent a par-
tial hand amputation of the fourth and fifth digits, includ-
ing their metacarpal bones, on postoperative day 20. This
patient died 9 months postoperatively for complications
related to ischemic bowel.
Two additional patients sustained graft occlusion dur-
ing the follow-up period, which averaged 12 months
(range, 1 to 50 months). One patient, a 53-year-old man
who was an active smoker with a history of diabetes,
hypertension, and congestive heart failure, had under-
gone an axillobrachial bypass with reversed great saphe-
nous vein for atherosclerotic occlusive disease causing
rest pain (Table III, patient 7). This patient was noted to
have graft occlusion on a follow-up visit 4 months post-
operatively. Revision was not attempted, and he contin-
ued to have only mild ischemic symptoms at follow-up
41 months postoperatively.
The third patient with graft occlusion was a 49-year-old
woman who had undergone a brachial-to-ulnar artery by-
pass with reversed great saphenous vein for exercise intol-
Table II. Differences between atherosclerosis vs
previously untreated trauma subgroups
Variable
Atherosclerosis
(n  7)
Previously untreated
trauma (n  13)
Renal failure 4 1
Previous leg bypass 5 3
Bypass indications
Tissue loss 6 0
Rest pain 1 2
Exertional symptoms 0 11
Infrabrachial outflow 5 3erance resulting from brachial artery occlusion related to
thylen
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cluded on postoperative day 31. No revision was at-
tempted, and she was noted to have developed a palpable
radial pulse 4 months postoperatively. At follow-up 50
months after her bypass, she was asymptomatic.
In addition to the patient with partial hand amputation
(Table III, patient 1), a second patient underwent a third
finger amputation. This 38-year-old man had a history of
diabetes mellitus, hypertension, coronary artery disease,
and chronic renal failure on peritoneal dialysis. He under-
went a brachial-to-radial artery bypass with reversed great
saphenous vein for atherosclerotic occlusive disease causing
finger gangrene (Table III, patient 3). Despite continued
patency of the graft and meticulous wound care, the finger
failed to heal, necessitating a finger amputation on postop-
erative day 49.
Primary patency, secondary patency, and limb salvage
were 85%, 85%, and 100%, respectively, at 1 and 3 years.
Patient survival was 77% at 1 year and 56% at 3 years. Of
note, 3-year patient survival after bypass was 0% for the
renal failure population versus 100% for those without renal
failure (Fig 1).
DISCUSSION
Upper extremity arterial reconstruction is an infre-
Table III. Patient information
Patient Sex DM Dialysis Etiology Trauma mechanism
1 F Yes Yes Chronic N/A Fin
2 F Yes Yes Chronic N/A Ha
p
3 M Yes Yes* Chronic N/A Ne
4 F Yes Yes Chronic N/A Ulc
5 M Yes No Chronic N/A Pu
6 M Yes No Chronic N/A Fin
7 M Yes No Chronic N/A Re
8 M No Yes Trauma Prev blunt trauma Ha
9 F Yes No Trauma Cardiac cath access Ha
t
10 F No No Trauma Mot cycle crash 4
mon prior
Ha
t
11 M No No Trauma Fall, elbow
dislocation
Ex
12 M No No Trauma Stab wound to
antecubital fossa
Nu
s
13 F No No Trauma Motor vehicle crash Nu
14 F No No Trauma Cardiac cath access Par
n
15 M No No Trauma Thromboembolism
4 mon prior
Arm
n
16 F No No Trauma Cardiac cath access Co
17 F No No Trauma Cardiac cath access Arm
18 F No No Trauma Cardiac cath access Arm
s
19 M No No Trauma Brach art laceration
20 yrs prior
We
r
20 F No No Trauma Fall; landed on arm Co
DM, Diabetes mellitus; LOS, length of stay in days; PTFE, polytetrafluoroe
*Peritoneal.quently performed operation, accounting for approxi-mately 4% of all vascular surgical procedures.7,8 First re-
ported by Garrett et al9 in 1965, relatively few reports on
the subject have been published. Publications focusing on
brachial artery reconstruction are particularly rare in the
literature. This is one of the few studies available on by-
passes to the brachial and infrabrachial arteries for the
treatment of chronic ischemia.
As noted by Roddy et al,10 unique demographic differ-
ences exist between upper and lower extremity bypass
populations. Patients with upper extremity reconstruction
typically presented at a relatively early age (average age, 57
in our study and 58 in Roddy et al) with a female prepon-
derance (55% women in our study and 55% women in
Roddy et al). In contrast, a contemporary cohort of lower
extremity bypasses performed at our institution had a mean
age of 67 with a primarily male preponderance (62%).5
Similar to Roddy et al, we also noted a statistically
significant difference in the incidence of diabetes mellitus of
40% in upper extremity bypass patients compared with 83%
in the lower extremity bypass population. Differences in the
incidence of hypertension, coronary artery disease, conges-
tive heart failure and tobacco use were not statistically
significant (Table IV). Most striking, however, was the
difference in the indication for bypass, with 55% of upper
extremity patients having exercise intolerance (claudication
mptoms Inflow Outflow Conduit LOS
Prev leg
bypass
angrene Brachial Radial Cephalic 3 Yes
cer, gangrene; Brachial Radial Cephalic 2 Yes
hand Brachial Radial Saphenous 2 Yes
on, numbness Brachial Brachial PTFE 1 Yes
finger ulcers Brachial Ulnar Cephalic 4 No
lcer Ulnar Ulnar Saphenous 2 Yes
n Axillary Brachial Saphenous 7 No
in, numbness Brachial Radial Saphenous 4 No
st pain,
g
Axillary Brachial PTFE 6 Yes
mbness,
g
Brachial Ulnar Saphenous 2 No
al sympt Brachial Radial Saphenous 2 No
ss, exertional Brachial Brachial Saphenous 1 No
rm Axillary Brachial Saphenous 5 No
sia, finger
ness
Brachial Brachial Cephalic 5 No
kness,
ness
Axillary Brachial Saphenous 7 No
mb hand Brachial Brachial Cephalic 1 Yes
bness Axillary Brachial Basilic 4 No
n, exertional Brachial Brachial Basilic 2 Yes
s, paresthesia,
in
Brachial Brachial Saphenous 4 No
inful hand Axillary Brachial Saphenous 6 No
e.Sy
ger g
nd ul
ain
crotic
erati
rulent
ger u
st pai
nd pa
nd re
inglin
nd nu
inglin
ertion
mbne
ympt
mb a
esthe
umb
wea
umb
ol, nu
num
pai
ympt
aknes
est pa
ol, paequivalent) as their indication compared with only 6% of
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tirely surprising, because the inability to use an arm would
be expected to be more likely to interfere with one’s activ-
ities of daily living. The benign postoperative course seen in
this series, with absence of mortality or any major postop-
erative complication may, perhaps, justify the high percent-
age of patients whose surgical indication was exercise intol-
erance.
It must be emphasized that comparison with a lower
Fig 1. Kaplan-Meier survival curve compares patients u
and without (solid line) renal failure.
Table IV. Demographics
Variable*
Upper extremity,
n (%)
Lower extremity,
n (%) P
Total patients 20 962
Age, mean years
(range) 57 (34-80) 67 (27-96)
Male 9 (45) 595 (62) .125
Tobacco use
Current 6 (30) 191 (20) .262
Former 6 (30) 530 (55) .026
Never 8 (40) 241 (25) .128
Hypertension 9 (45) 566 (59) .241
Coronary artery
disease 10 (50) 441 (46) .721
Congestive heart
failure 1 (5) 161 (17) .162
Diabetes 8 (40) 795 (83) .001
*Continuous data presented as mean, range; categoric data as number (%)extremity bypass population could only be made in themost general of terms because these two groups of patients
differ largely in terms of their etiology of occlusive disease.
Although the small patient sample size does not allow us to
authoritatively conclude, the trends may allow one to spec-
ulate that as would most likely be expected, the atheroscle-
rotic subpopulation of upper extremity bypass patients is
most likely to behave like the typical peripheral arterial
disease patient seen in a vascular surgical practice (Table II).
Our patency and limb salvage rates of 85% and 100%
respectively at 1 year are similar to what has been previously
reported in the literature. Roddy et al10 reported a 1-year
patency of 90% and limb salvage rate of 100%, and Brunk-
wall et al11 reported a 1-year patency rate of 96%. It has
been previously noted that more proximal reconstructions
to the brachial artery tend to fare better than bypasses to the
infrabrachial arteries, analogous to what is commonly
known in lower extremity arterial reconstruction.1 Unfor-
tunately, our small sample size did not allow us to make
going upper extremity arterial bypass with (dashed line)
Table V. Indications for bypass
Indication
Lower extremity,
n (%)
Upper extremity,
n (%)
Exertional symptoms 58 (6) 11 (55)
Rest pain 30 (3) 6 (30)
Tissue loss 855 (89) 3 (15)
Failing graft 19 (2) —ndermeaningful comparisons between these two groups.
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series who required an amputation (finger amputation and
partial hand amputation) were both patients with dialysis-
dependent renal failure. This is not surprising, because the
propensity for finger gangrene to develop in chronic renal
failure patients has been previously noted.12 Even though
the subpopulation of renal failure patients in this study had
a benign postoperative course, it is important to note that
the tendency of this patient population toward a poor
postoperative course after both upper and lower extremity
arterial reconstruction has been well documented by us and
others.13,14
The difference in 3-year patient survival of 0% for the
renal failure population versus 100% for those without
renal failure achieved statistical significance (Fig), sug-
gesting that the need for an upper extremity bypass in a
renal failure patient may well be a clinical marker for
pending mortality.12 One important limitation of this
study is that functional outcome data were not recorded.
This shortcoming prevents us from the ability to assess if
revascularization led to an improvement in the work
status of these patients.
CONCLUSION
Upper extremity arterial reconstruction for the treat-
ment of chronic ischemia may be safely undertaken with
excellent results. That the etiology of ischemia for most of
the patients undergoing bypass was for previously un-
treated trauma rather than atherosclerosis may account for
the superior patency observed compared with those re-
ported for lower extremity bypass. It is our belief that
bypass to the brachial and infrabrachial arteries may be
offered to appropriately selected patients with upper ex-
tremity ischemia.
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